mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting

Cited by papers we hold 7

• CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors · 2024
  No notice
• Challenges and new technologies in adoptive cell therapy · 2023
  No notice
• The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies · 2023
  No notice
• CAR-T: What Is Next? · 2023
  No notice
• Gene modification strategies for next-generation CAR T cells against solid cancers · 2020
  No notice
• Recent advances in CAR-T cell engineering · 2020
  No notice
• Universal CARs, universal T cells, and universal CAR T cells · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.